A detailed history of Klp Kapitalforvaltning As transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 49,600 shares of FOLD stock, worth $346,208. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,600
Previous 42,200 17.54%
Holding current value
$346,208
Previous $344,000 17.44%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 23, 2025

BUY
$5.64 - $8.0 $41,736 - $59,200
7,400 Added 17.54%
49,600 $284,000
Q1 2025

May 06, 2025

SELL
$8.16 - $9.85 $55,488 - $66,980
-6,800 Reduced 13.88%
42,200 $344,000
Q4 2024

Feb 11, 2025

BUY
$9.36 - $12.01 $458,640 - $588,490
49,000 New
49,000 $461,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $1.96B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.